Aktis Oncology annual operating margin
2024
2025
Aktis Oncology Operating Margin Growth & History (AKTS)
Aktis Oncology's operating margin was −1,149.52% for fiscal 2025.
View full Aktis Oncology company overviewAktis Oncology annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,149.52% | +2350.82 pp |
| 2024 | 2024-12-31 | −3,500.34% | — |
Aktis Oncology quarterly operating margin
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −853.99% | +455.38 pp |
| Q1 2026 | 2026-03-31 | −703.63% | +550.21 pp |
| Q4 2025 | 2025-12-31 | −929.14% | +746.63 pp |
| Q3 2025 | 2025-09-30 | −1,152.82% | — |
| Q2 2025 | 2025-06-30 | −1,309.37% | — |
| Q1 2025 | 2025-03-31 | −1,253.84% | — |
| Q4 2024 | 2024-12-31 | −1,675.78% | — |
Aktis Oncology operating margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Aktis Oncology's operating margin increased from −3,500.34% to −1,149.52%, a change of +2350.82 percentage points. The latest reported quarter, Q2 2026, shows −853.99%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aktis Oncology source filings ↗